Clinical Trial Update: Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of dupilumab in patients with persistent asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 3 | Status: COMPLETED